Clinical Trials Directory

Trials / Conditions / Intraabdominal Infections

Intraabdominal Infections

13 registered clinical trials studyying Intraabdominal Infections — 2 currently recruiting.

StatusTrialSponsorPhase
RecruitingThe Role of Circadian Clock Proteins in Innate and Adaptive Immunity
NCT03482245
Washington University School of MedicineN/A
CompletedA Study of Levornidazole Disodium Phosphate for Injection vs. Ornidazole in Treatment of Postoperative Intra-A
NCT06828874
Yangtze River Pharmaceutical Group Jiangsu Zilong Pharmaceutical Co. LtdPhase 4
CompletedIntra-Abdominal Sepsis and Relationship Between Cumulative Fluid Balance and Serum Sodium and Chloride Levels
NCT06838585
Clinical Center of Vojvodina—
WithdrawnSafety, Tolerability, and Pharmacokinetics of Sulopenem in Adolescents
NCT04700787
Iterum Therapeutics, International LimitedPhase 1
CompletedA Phase 2 Study Evaluating Efficacy, Safety and Tolerability of Different Doses and Regimens of Allocetra-OTS
NCT04612413
Enlivex Therapeutics Ltd.Phase 2
UnknownPrediction of Intra-abdominal Infectious Complication by Drainage Fluid Analysis
NCT03862378
Peking University—
CompletedHostDx Sepsis in the Diagnosis and Prognosis of Emergency Department Patients With Suspected Infections: a Mul
NCT03744741
Inflammatix—
CompletedMulticentre Observational Study on Community Acquired Intraabdominal Infections Management
NCT03544203
Centre Hospitalier Universitaire de Nīmes—
RecruitingFosfomycin I.v. for Treatment of Severely Infected Patients
NCT02979951
Infectopharm Arzneimittel GmbH—
UnknownPrognostic Value of Proadrenomedullin in Intra-abdominal Sepsis
NCT03061500
Instituto de Investigación Hospital Universitario La Paz—
CompletedPoint of Care 3D Ultrasound for Various Applications: A Pilot Study
NCT02831556
Duke University—
CompletedMoxifloxacin in Pediatric Subjects With Complicated Intra-abdominal Infection
NCT01069900
BayerPhase 3
CompletedA Study of the Safety and Effectiveness of Doripenem in Filipino Patients With Nosocomial Pneumonia, Complicat
NCT01763008
Janssen Pharmaceutica—